 After a long and painful downside, TFFPs stock has finally delivered a one-day outperformance with respect to the big Covid plays due to the Omicron variant. The next question is whether this is just another blip as was the case in July when there were positive clinical trials results for Augmentas drug candidate using TFF Thin Film Freezing delivery. 